For most patients, these symptoms are most intense during the titration phase and diminish as the body adjusts to stable doses
Tighter oversight of manufacturers pricing policies and the competitive environment Its unseemly (polite word choice) that the CEO of Lilly, Dave Ricks, is able to rake in total compensation of $114 million in 2024 while at the same time acknowledging that the price his company charges for Zepbound is too high. Unseemly, because his payday was fueled by Lilly making more than $10 billion in profit from GLP-1s in 2024 alone
The objectives were to comprehensively evaluate the psychiatric AEs associated with GLP-1 RAs and to characterize the clinical features observed in the reported cases
They can answer your questions and help you determine if Steps 2 and 3 are right for you
Side effects tend to be manageablenausea comes up the most, especially early on, but it often fades as things level out
overweight doesnt mean that you are ill, and being slim doesnt mean that you are healthy